EssilorLuxottica Total Current Assets 2011-2024 | ESLOY
- EssilorLuxottica total current assets for the quarter ending December 31, 2024 were $10.860B, a 4.07% decline year-over-year.
- EssilorLuxottica total current assets for 2023 were $10.521B, a 15.56% increase from 2022.
- EssilorLuxottica total current assets for 2022 were $9.104B, a 16.34% decline from 2021.
- EssilorLuxottica total current assets for 2021 were $10.882B, a 30.56% decline from 2020.
EssilorLuxottica Annual Total Current Assets (Millions of US $) |
|
---|---|
2023 | $10,521 |
2022 | $9,104 |
2021 | $10,882 |
2020 | $15,672 |
2019 | $12,040 |
2018 | $8,297 |
2017 | $3,944 |
2016 | $3,883 |
2015 | $3,633 |
2014 | $4,203 |
2013 | $4,026 |
2012 | $3,635 |
2011 | $3,383 |
2010 | $2,711 |
EssilorLuxottica Quarterly Total Current Assets (Millions of US $) |
|
---|---|
2024-12-31 | $10,860 |
2023-12-31 | $10,521 |
2023-06-30 | $9,882 |
2022-12-31 | $9,104 |
2022-06-30 | $11,321 |
2021-12-31 | $10,882 |
2021-06-30 | $17,698 |
2020-12-31 | $15,672 |
2020-06-30 | $14,347 |
2019-12-31 | $12,040 |
2018-12-31 | $8,297 |
2018-06-30 | $4,501 |
2017-12-31 | $3,944 |
2017-06-30 | $4,088 |
2016-12-31 | $3,883 |
2015-12-31 | $3,633 |
2015-06-30 | $3,793 |
2014-12-31 | $4,203 |
2014-06-30 | $4,306 |
2013-12-31 | $4,026 |
2013-06-30 | $3,640 |
2012-12-31 | $3,635 |
2012-06-30 | $3,569 |
2011-12-31 | $3,383 |
2011-06-30 | $3,078 |
2010-12-31 | $2,711 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $130.320B | $28.687B |
EssilorLuxottica Soci?t? is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company's brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Soci?t?, formerly known as Essilor International Soci?t? Anonyme, is based in Paris, France. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $240.237B | 28.89 |
Boston Scientific (BSX) | United States | $154.040B | 38.56 |
Stryker (SYK) | United States | $147.507B | 30.84 |
Medtronic (MDT) | Ireland | $110.401B | 15.65 |
Lonza Group Ag (LZAGY) | Switzerland | $51.194B | 0.00 |
Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
ResMed (RMD) | United States | $37.523B | 28.18 |
Agilent Technologies (A) | United States | $33.417B | 21.78 |
GE HealthCare Technologies (GEHC) | United States | $32.959B | 15.65 |
Terumo (TRUMY) | Japan | $27.294B | 35.45 |
Koninklijke Philips (PHG) | Netherlands | $23.014B | 16.15 |
Insulet (PODD) | United States | $21.880B | 85.88 |
Zimmer Biomet Holdings (ZBH) | United States | $18.269B | 11.73 |
Baxter (BAX) | United States | $15.698B | 11.72 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.073B | 0.00 |
Demant (WILYY) | Denmark | $9.110B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.474B | 22.53 |
Lantheus Holdings (LNTH) | United States | $5.601B | 14.13 |
Prestige Consumer Healthcare (PBH) | United States | $4.184B | 18.69 |
Perrigo (PRGO) | Ireland | $3.678B | 9.32 |
Haemonetics (HAE) | United States | $3.510B | 15.99 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
ICU Medical (ICUI) | United States | $3.221B | 23.75 |
Envista Holdings (NVST) | United States | $3.210B | 26.68 |
GN Store Nord (GNNDY) | Denmark | $2.346B | 19.43 |
QuidelOrtho (QDEL) | United States | $1.939B | 13.34 |
LeMaitre Vascular (LMAT) | United States | $1.916B | 42.83 |
AtriCure (ATRC) | United States | $1.621B | 0.00 |
Acuren (TIC) | United States | $1.311B | 0.00 |
AdaptHealth (AHCO) | United States | $1.182B | 12.00 |
Neogen (NEOG) | United States | $1.070B | 13.69 |
Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
Phibro Animal Health (PAHC) | United States | $1.004B | 12.83 |
Kestra Medical Technologies (KMTS) | United States | $0.906B | 0.00 |
InMode (INMD) | Israel | $0.870B | 8.76 |
CeriBell (CBLL) | United States | $0.710B | 0.00 |
Evolus (EOLS) | United States | $0.620B | 0.00 |
Owens & Minor (OMI) | United States | $0.578B | 4.79 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.568B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.519B | 0.00 |
Valneva SE (VALN) | France | $0.477B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.423B | 0.00 |
Surmodics (SRDX) | United States | $0.415B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.384B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.328B | 12.05 |
SNDL (SNDL) | Canada | $0.326B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.279B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.274B | 23.10 |
Cerus (CERS) | United States | $0.262B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
ZimVie (ZIMV) | United States | $0.247B | 11.22 |
Brainsway (BWAY) | Israel | $0.232B | 61.30 |
Canopy Growth (CGC) | Canada | $0.230B | 0.00 |
Quanterix (QTRX) | United States | $0.229B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.228B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.224B | 66.33 |
Biote (BTMD) | United States | $0.218B | 6.14 |
Omeros (OMER) | United States | $0.198B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.198B | 0.00 |
Organigram Global (OGI) | Canada | $0.182B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.181B | 14.74 |
High Tide (HITI) | Canada | $0.177B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
Exagen (XGN) | United States | $0.150B | 0.00 |
Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
FitLife Brands (FTLF) | United States | $0.121B | 14.84 |
Jin Medical (ZJYL) | China | $0.103B | 0.00 |
Veru (VERU) | United States | $0.098B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
Fonar (FONR) | United States | $0.088B | 11.32 |
Apyx Medical (APYX) | United States | $0.086B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
MacroGenics (MGNX) | United States | $0.085B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
Zynex (ZYXI) | United States | $0.076B | 0.00 |
Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
InterCure (INCR) | Israel | $0.069B | 0.00 |
Agape ATP (ATPC) | $0.065B | 0.00 | |
ImmuCell (ICCC) | United States | $0.062B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
Nephros (NEPH) | United States | $0.044B | 59.43 |
Modular Medical (MODD) | United States | $0.043B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.89 |
Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
Safety Shot (SHOT) | United States | $0.023B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
INLIF (INLF) | $0.014B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
Senestech (SNES) | United States | $0.007B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |